Invesco Biotechnology & Genome ETF (PBE) Holdings $68.11 -0.25 (-0.37%) As of 02/21/2025 04:10 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatings Top 33 PBE HoldingsRankCompanyCurrent PriceWeightShares Held1GILDGilead Sciences$109.95-0.1%6.03%140,7562NTRANatera$162.31-3.5%5.32%77,4813UTHRUnited Therapeutics$361.10-1.7%5.24%34,5504AMGNAmgen$303.01+1.7%5.08%43,3245INCYIncyte$72.05+0.9%4.84%173,2476REGNRegeneron Pharmaceuticals$700.33+0.6%4.64%16,9957BIIBBiogen$140.64+2.6%4.37%80,2558ILMNIllumina$94.20-3.1%3.63%88,5649AXSMAxsome Therapeutics$137.75+6.7%3.60%71,25710BCRXBioCryst Pharmaceuticals$9.21-1.9%3.57%955,642 Get the Latest News and Ratings for PBE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter. 11RPRXRoyalty Pharma$33.42+0.3%3.41%262,46812HALOHalozyme Therapeutics$57.75+0.5%3.34%145,37713ACADACADIA Pharmaceuticals$19.95-1.7%3.29%420,04314CPRXCatalyst Pharmaceuticals$21.63-1.9%2.94%327,86715CDNACareDx$22.29-4.7%2.83%288,16016VCYTVeracyte$39.18-4.6%2.83%169,03917BMRNBioMarin Pharmaceutical$68.25-0.7%2.79%106,73618BPMCBlueprint Medicines$92.25-2.2%2.77%74,01219COLLCollegium Pharmaceutical$29.13-2.1%2.69%225,64220EXELExelixis$36.85+5.0%2.67%190,97221MYGNMyriad Genetics$14.19-5.3%2.62%442,23522SRPTSarepta Therapeutics$106.28-2.0%2.58%60,59923EXASExact Sciences$49.26-0.5%2.53%125,99824QGENQiagen$39.52+2.5%2.51%160,57425NBIXNeurocrine Biosciences$120.69+3.9%2.49%54,65826TGTXTG Therapeutics$30.88-0.2%2.48%200,73727TECHBio-Techne$64.92-0.9%2.45%93,39328PTGXProtagonist Therapeutics$38.75+0.7%2.34%152,59229MNKDMannKind$5.77+1.9%2.27%1,033,85730XNCRXencor$15.74-0.3%1.72%266,59731Short-Term Investment Trust - Invesco Government & Agency PortfolioN/A0.13%318,10432CashN/A0.00%5,69033Securities Lending - BnymN/A0.00%1 Geographic ExposureUnited States97.5%Netherlands2.5%Currency ExposureUSD100.0%Sector ExposureHealth Care93.9%Industry ExposureBiotechnology72.9%Health Care Equipment & Supplies16.0%Health Care Providers & Services5.0%SubIndustry ExposureBiotechnology68.9%Life Sciences Tools & Services13.4%Health Care Services5.0%Pharmaceuticals3.9%Health Care Equipment2.6%Coupon Exposure4-60.1% Related Companies and Tools Related Companies Invesco Pharmaceuticals ETF Portfolio SPDR S&P Health Care Equipment ETF Portfolio Invesco S&P SmallCap Health Care ETF Portfolio Direxion Daily Healthcare Bull 3x Shares Portfolio SPDR S&P Pharmaceuticals ETF Portfolio Simplify Health Care ETF Portfolio Invesco Dorsey Wright Healthcare Momentum ETF Portfolio VanEck Biotech ETF Portfolio ALPS Medical Breakthroughs ETF Portfolio SPDR S&P Health Care Services ETF Portfolio This page (NYSEARCA:PBE) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PBE Stock Alerts